Participations à des congrès et colloques internationaux (39)
  1. 32. Grieco, F. A., Moore, F., Vigneron, F., Santin Gomez, I., Marselli, L., Rondas, D., Overbergh, L., Dotta, F., Mathieu, C., Marchetti, P., & Eizirik, D. L. (2013). IL-17 increases the expression and release of pro-inflammatory chemokines by human pancreatic islets. Poster présenté à la conférence EASD 2013, 49th Annual Meeting of the European Association for the Study of Diabetes (23 - 27 September: Barcelona, Spain. (Poster)).
  2. 33. Igoillo Esteve, M., Genin, A., Lambert, N., Désir, J., Pirson, I., Abdulkarim, B., Simonis, N., Drielsma, A., Marselli, L., Marchetti, P., Vanderhaeghen, P., Eizirik, D. L., Wuyts, W., Julier, C., Chakera, A. J., Ellard, S., Hattersley, A. T., & Abramowicz, M. (2013). tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans. Paper session presented at Belgian Medical Genomics Initiative (BeMGI) Kickoff Meeting (2013: Leuven, Belgium).
  3. 34. Igoillo Esteve, M., Genin, A., Lambert, N., Désir, J., Pirson, I., Abdulkarim, B., Simonis, N., Drielsma, A., Marselli, L., Marchetti, P., Vanderhaeghen, P., Eizirik, D. L., Wuyts, W., Julier, C., Chakera, A. J., Ellard, S., Hattersley, A. T., & Abramowicz, M. (2013). Loss-of-function of TRMT10A causes young onset diabetes and microcephaly. Paper session presented at 23rd Meeting of the Belgian Endocrine Society (2013: Ghent, Belgium).
  4. 35. Andrade Da Cunha, D., Gurzov, E. N., Ortis, F., Naamane, N., Bugliani, M., Marchetti, P., & Eizirik, D. L. (2013). The transcription factor JunB protects pancreatic beta cells from lipotoxicity by induction of the ER stress response gene XBP1 and AKT signalling. Paper session presented at 49th EASD Annual Meeting (2013: Barcelona, Spain).
  5. 36. Grieco, F. A., Moore, F., Vigneron, F., Santin Gomez, I., Marselli, L., Overbergh, L., Mathieu, C., Dotta, F., Marchetti, P., & Eizirik, D. L. (2012). IL-17 increases the expression and release of pro-inflammatory chemokines by human pancreatic islets. Poster présenté à la conférence ISG 2012, 22th Islet Study Group Symposium (5 - 7 October 2012: Rostock, Germany. (Poster)).
  6. 37. Santin Gomez, I., Moore, F., Grieco, F. A., Marchetti, P., Brancolini, C., & Eizirik, D. L. (2012). USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inframmation and apoptosis. Poster présenté à la conférence ISG 2012, 22th Islet Study Group Symposium (5 - 7 October 2012: Rostock, Germany (Poster)).
  7. 38. Igoillo Esteve, M., Serroukh, Y., Rai, M., Depondt, C., Musuaya, A., Ladrière, L., Marhfour, I., Marchetti, P., Koeppen, A., Pandolfo, M., Eizirik, D. L., & Fery, F. (2011). Pancreatic beta-cell dysfunction and death cause diabetes in Friedreich’s ataxia. Paper session presented at 21st Meeting of the Belgian Endocrine Society (2011: Leuven. Belgium).
  8. 39. Andrade Da Cunha, D., Gurzov, E. N., Naamane, N., Germano, C. M., & Eizirik, D. L. (2011). Lipotoxic ER stress-induced DP5 and PUMA contribute to mitochondrial beta-cell apoptosis. Paper session presented at 21st EASD Islet Study Group Meeting (2011: Natal, Brazil).
    9.   Brevets (6)
  9. 1. Colli, M. L., Eizirik, D. L., Mallone, R., Vinh, J., Verdier, Y., Afonso, G., & Gonzalez-Duque, S. (2018). ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES.
  10. 2. Eizirik, D. L., et al. (2016). A new biomarker expressed in pancreatic beta cells useful in imaging of targeting beta cells.
  11. 3. Eizirik, D. L., et al. (2016). A new biomarker expressed in pancreatic beta cells useful in imaging of targeting beta cells.
  12. 4. Cnop, M., Eizirik, D. L., Fuks, F., & Volkmar, M. (2011). Methylation patterns of type 2 diabetes patients.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 Suivant >>